Complications associated with the use of iohexol for myelography of the cervical vertebral column in dogs: 66 cases (1988-1990).
Medical records of 66 dogs that had undergone myelography, using iohexol (240 mg of iodine/ml, 0.3 to 0.5 ml/kg of body weight) during a 2-year period, were reviewed. In 3 dogs, myelography was performed twice during different anesthetic procedures. Neurologic abnormalities were more pronounced the day after myelography in dogs with caudal cervical spondylomyelopathy (P less than 0.01), meningitis (P less than 0.01), or extradural tumors (P less than 0.05). Neither anesthetic regimen nor duration of anesthesia significantly affected the frequency of complications. Seizures occurred after myelography in 6 dogs, and 1 dog had seizures after each of 2 myelographic procedures. The frequency of seizures was significantly greater in male Doberman Pinschers afflicted with caudal cervical spondylomyelopathy. Male dogs (P less than 0.01) and Doberman Pinschers (P less than 0.001) had higher prevalence of seizures. Caudal cervical spondylomyelopathy was associated with higher prevalence of seizures, compared with all other diagnoses (P less than 0.001). Seizures were significantly more prevalent when body weight was greater than or equal to 29 kg (P less than 0.001), when greater than or equal to 2 injections of contrast medium were administered (P less than 0.016), or when 2 injections of contrast medium were given at the cisterna magna (P less than 0.015). The 10% prevalence of seizures after myelography with iohexol in the study reported here is greater than in previous reports, but is lower than that reported after myelography using metrizamide.
Lewis
D D
DD
Department of Veterinary Clinical Sciences, School of Veterinary Medicine, Louisiana State University, Baton Rouge 70803.
Hosgood
G
G
D000768:Anesthesia, General / Q000662:veterinary; D000818:Animals; D001947:Breeding; D004283:Dog Diseases / Q000139:chemically induced / Q000209:etiology*; D004285:Dogs; D005260:Female; D007472:Iohexol / Q000009:adverse effects*; D008297:Male; D009192:Myelography / Q000009:adverse effects / Q000662:veterinary; D011229:Preanesthetic Medication / Q000662:veterinary; D015995:Prevalence; D012189:Retrospective Studies; D012640:Seizures / Q000139:chemically induced / Q000209:etiology / Q000662:veterinary*; D012737:Sex Factors
D007472:Iohexol